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1. Introduction
 
  Apical hypertrophic cardiomyopathy (ApHCM) is a 
special type of hypertrophic cardiomyopathy (HCM), 
presenting as pathological cardiac hypertrophy of the 
apical wall, and fornical appearance during diastolic 
period. Though prognosis of ApHCM is good, arrhythmia 
and fetal aneurysm still occurred occasionally. Application 
of Doppler ultrasound in diagnosis of ApHCM might has 
limitation. However, it has demonstrated that cardiovascular 
magnetic resonace (CMR) has its advantages on detecting 
morphological changes of left ventricular. Furthermore, the 
progress of the study on late gadolinium enhancement (LGE) 
is enabling a new diagnosis tool for cardiomyopathy become 
possible. Some studies have confirmed the specificity and 
sensitivity of LGE for diagnosis of septal cardiomyopathy. 
But the evidence with apical cardiomyopathy is rare and 
there exist many controversies upon its LGE enhancement 
features. In this study, we aim to reveal the frequency and 
distribution of LGE acquired by PSIR among the ApHCM 
patients and further determine the diagnosis value of LGE 
for ApHCM.
2. Materials and methods
2.1.  Patients general data
   A total of 40 asymptomatic ApHCM patients were enrolled. 
The following diagonisis standard was followed. Asymmetric 
left ventricular (LV) hypertrophy restricted within apical 
area; thickness 曒15 mm; Thickest of apical versus 
thickest of substrate曒 1.3 (CMR); Patients with coronary 
atheroaclerotic heart disease were excluded. All subjects 
have signed informed consent forms.
2.2. CMR imaging
   CMR was operated with 3.0 T medical nuclear magnetic 
resonance scanner (SIMENS Trio TIM, Siemens, Erlangen, 
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Objective: Late gadolinium enhancement (LGE) patterns of cardiovascular magnetic resonance 
(CMR) relying on PSIR (phase-sensitive inversion recovery sequence) techniques had been 
used to determine the characteristics of LGE in apical hypertrophic cardiomyopathy (ApHCM). 
Methods: Forty patients pure ApHCM [age, (60.2±10.4) years, 31 men] were enrolled. LGE images 
were acquired using PSIR, and analyzed using a 17-segment model. Summing the LGE areas 
in all short axis slices yielded the total volume of late enhancement, which was subsequently 
presented as a proportion of total LV myocardium (% LGE). Results: Mean maximal apical wall 
thickness was (17.9±2.3) mm, and mean left ventricular (LV) ejection fraction was (67.7±8.0)%. LGE 
was detected in 130 segments of 30 patients (75.0%), occupying (4.9±5.5)% of LV myocardium. LGE 
was mainly detected at the junction between left and right ventricles in 12 (30%) and at the apex in 
28 (70%), although LGE-positive areas were widely distributed, and not limited to the apex. Focal 
LGE at the non-hypertrophic LV segments was found in some ApHCM patients, even without 
LGE of hypertrophied apical segments. Conclusions: LGE was frequently observed not only in 
the thickened apex of the heart but also in other LV segments, irrespective of the presence or 
absence of hypertrophy. The simple presence of LGE on CMR was not representative of adverse 
prognosis in this population.
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Germany, 32 channel). Receiving coil is 32 channel cardiac 
coil. Imaging sequence: cine true FISP; left ventricular 
volume measurement parameter is 6mm for imaging layer 
from apical to bottom, 
   Time resolution is 25-30/RR interval; LV quality parameter 
is obtained with commercial software (SIMENS Arugs, eonado 
Workstation). LGE acquisition range includes left ventricular 
long-axis, short-axis and 4 chambers. The imaging 
sequence is PSIR. Phase map and amplitude map were 
established at the same position. LGE imaging analysis was 
made with 17-segment model and followed the American 
Heart Association criteria. LV is divided into segments of 
cardiac base, cardiac waist and apical. The heart basal and 
cardiac waist is further divided into 6 ssegments; apical area 
was divided into 4 segments; and the apical cap was divided 
into 17 segments (Figure 1).
 
2.3. Graphic data analysis
  Data is processed with SIMENS workstation ARGUS. The 
assessment index includes left ventricular ejection fraction, 
left ventricular mass, etc. 6 standard daviation higher 
than normal myocardial is regarded as LGE enhancement. 
The total volume of late enhancement was presented as a 
proportion of total LV myocardium (%LGE). LGE area was 
obtained by double blind method of Doctor Gao.
 
2.4. Statistical analysis
   17 segment model was used calculate LGE index, LV mass 
index and variation was analyzed. normally distributed 
variables were analyzed by non-paired t test. Non-normally 
distributed variables were analyzed by U test. LV thickening 
rate was determined by comparison of thickening rate and 
absolute value of LV end-diasolic and end systolic with 
LGE. All data are presented as mean±S. software SPSS 13.0 
is used for tatistical analysis. P value of less than 0.05 was 
considered significance.
3. Results
3.1. Clinical characteristic
   Subjects included 31 males and 9 females, age ranging 
from 28 to 80 years, median 59 years. 25 subjects were 
asymptomatic and 15 subjects presented mild symptoms 
(NYHA I or II). 17 subjects had hypertensive history. 39 
patients presented T wave inversion. 12 patients presented 
high and large retrograde wave (Figure 1D).
3.2. Cardial MR
 
   LV wall thickness and LGE characteristic of 680 sections 
were analyzed (left ventricular mass index was (102.0±28.9) g/
m2. ejection fraction was (67.7±8.0)% (Table 1 and Figure 1). 
Thickest apical wall was 15 mm to 26 mm [(17.9±2.3) mm]. 
LGE enhancement was detected in 130 (19%) segments of 
30 patients (75%). Enhancement volume was (9.7±10.0) mL, 
occupying (4.9±5.5)% of LV myocardium (range from 0.5% to 
26%). LGE enhancement was detected at the apical cap in 28 
patients and at the wall of apical in 20 patients (52.5%). It was 
distributed not only in the thickened apex of the heart, but 
also in other LV segments (Figure 2).
Figure 1. CMR showing patients with ApHCM had delayed 
enhancement. 
A-hypertrophied apical segment in the left ventricular long axis; 
B-short- axis; long-axis; C-pervasive enhancement in basal area of 
hypertrophied apical segment; D-negative T wave. Arrow indicates 
the LGE segment.
   Transmural LGE (曒75% ventricular wall thickness) was 
detected in only two patients (7%). Most LGE presented as 
limited, multi-centered or mixed. LGE were detected at sub-
endocardium in 47 patients, occupying 48% of 97 patients 
in whom LEG was detected at apical segments, which had 
similar profile with ischemic cardiomyopathy (Figure 3).
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Figure 2. LGE distribution in patients with ApHCM, apical and cap 
segment account for the most of this part (52.5% and 70.0%).
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Table 1
CMR.
LV end-diastolic volumn (mL) 130.5 ± 26.3
LV end-diastolic volumn index (mL/m2)   76.0 ± 13.9
LV end-systolic volumn (mL)   43.9 ± 18.1
LV end-systolic volumn index (mL/m2)   25.2 ± 9.1
LV ejection fraction (%)   67.7 ± 8.0
LV body mass (g)  178.0 ± 61.1
LV body mass index (g/m2)  102.2 ± 28.9
Maximum ventricular thickness of apical 
segment at end-diastolic phase (mm) 
   17.9 ± 2.3
Figure 3. LGE enhancement mode of ApHCM. 
A-Transmural type occupying more than 75% of LGE at sub-endocardium; 
B-Fused type of LGE; C-Multi-centered LGE distributed among RV 
interventricular septum and former partition; D-Focal-myocardium 
type.
4. Discussion
   ApHCM is a special type of HCM, presenting as deep 
T-wave inversion and fornical appearance of LV at end 
diastolic. Application of Regular echocardiography in 
diagnosis of ApHCM has limitation, which usually under-
evaluate the thickness of abnormal hypertrophied ventricular 
wall, or missed diagnosis due to the fact that ultrasonic 
probe is too close to the apical. However, CMR does not has 
those limitations and has high-soft-tissue resolution.
   In this study, we discover that myocardial fibrosis is 
common among the ApHCM patients. Apical segment 
including apical cap is the most common involved areas, 
though LGE is not limited at abnormal hypertrophied 
apical segment and also occurs at basal, front and back of 
ventricular septum and middle of free wall and septum. 
Importantly, LEG was detected at sub-endocardium in many 
cases, distinct with other HMCs in which LEG was frequently 
detected in ventricular wall. This feature of ApHCM patients 
suggest subendocardial ischemia of apical area is not caused 
by coronay disease, but probably caused by blood supply 
deficiency due to lack of enough coronary branches in 
abnormal hypertrophy apical walls. Furthermore, local high 
pressure at apical area might lead to deficiency blood supply 
at subendocardial, which may explain apical ischemia.
   Some HCM studies have demonstrated the correlation 
between LGE and myocardial collagen increase, but that of 
LGE patterns and ApHCM still need to be confirmed. This 
study suggest application of LGE upon ApHCM diagnosis 
need to be re-evaluated, in respect of pathology or imaging, 
and long term follow up and more pathology and physiology 
studies are needed.
   In conclusion, LGE is frequently presented in ApHCM. It 
was observed not only in the thickened apex of the heart, but 
also in other LV segments, irrespective of the presence or 
absence of hypertrophy. It is featured with enhancement of 
subendocardial, which is distinct from other types of HCM. 
It should be distinguished from subendocardial myocardial 
infarction caused by coronary.
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